Danish Study Finds Anti-Viral Paxlovid May Be Triggering Drug-to-Drug Interactions, Particularly in Elderly COVID-19 Patients
These findings may be useful to clinical laboratory professionals when physicians want guidance in effective treatments for COVID-19 patients, particularly when there are concerns about a rebound of the infection Drug interactions are a major concern for physicians and clinical laboratories. That is especially true given the push for nearly universal COVID-19 vaccinations and boosters. […]
The post Danish Study Finds Anti-Viral Paxlovid May Be Triggering Drug-to-Drug Interactions, Particularly in Elderly COVID-19 Patients appeared first on Dark Daily.
Source: Dark Daily - Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Aditya Shah MBBS anatomic pathology antivirals CDC centers for disease control and prevention clinical laboratory Columbia University Irving Med Source Type: news
More News: Centers for Disease Control and Prevention (CDC) | Covid Vaccine | COVID-19 | Denmark Health | Laboratory Medicine | Pathology | Study | Vaccines